Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Metyrosine | hsa00500 | Starch and sucrose metabolism | 1.32E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Metyrosine | hsa00730 | Thiamine metabolism | 3.83E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Metyrosine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Metyrosine | hsa01523 | Antifolate resistance | 3.80E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Metyrosine | hsa03010 | Ribosome | 1.03E-02 | 2 | P46777, P50914 | RPL5, RPL14 | More | | Metyrosine | hsa03020 | RNA polymerase | 9.80E-05 | 2 | Q9GZM3, P52435 | POLR2J2, POLR2J | More | | Metyrosine | hsa03050 | Proteasome | 3.05E-02 | 1 | P55036 | PSMD4 | More | | Metyrosine | hsa03060 | Protein export | 3.28E-02 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | | Metyrosine | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2 | EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2 | More | | Metyrosine | hsa04110 | Cell cycle | 6.80E-03 | 6 | P06493, O75293, P30304, P33981, P42773, P01106 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | | Metyrosine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Metyrosine | hsa04142 | Lysosome | 3.31E-02 | 3 | P43234, Q9UBR2, P34059 | CTSO, CTSZ, GALNS | More | | Metyrosine | hsa04144 | Endocytosis | 4.10E-02 | 3 | O75351, P62491, Q14161 | VPS4B, RAB11A, GIT2 | More | | Metyrosine | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | | Metyrosine | hsa04218 | Cellular senescence | 4.79E-02 | 4 | P01106, O75293, P30304, P06493 | MYC, GADD45B, CDC25A, CDK1 | More | | Metyrosine | hsa04340 | Hedgehog signaling pathway | 1.80E-02 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Metyrosine | hsa04621 | NOD-like receptor signaling pathway | 3.15E-02 | 10 | Q16539, Q14643, P21796, P10599, Q9H1Y0, P43490, O00463, P01375, P09341, P12838 | MAPK14, ITPR1, VDAC1, TXN, ATG5, PBEF1, TRAF5, TNF, CXCL1, DEFA4 | More | | Metyrosine | hsa04630 | JAK-STAT signaling pathway | 1.44E-02 | 4 | P01106, Q09472, P48551, P16871 | MYC, EP300, IFNAR2, IL7R | More | | Metyrosine | hsa04640 | Hematopoietic cell lineage | 1.75E-03 | 8 | P21926, P20023, P11836, P07766, P09693, P01730, P09564, P16871 | CD9, CR2, MS4A1, CD3E, CD3G, CD4, CD7, IL7R | More | | Metyrosine | hsa04650 | Natural killer cell mediated cytotoxicity | 1.83E-03 | 10 | P01375, P78314, P06239, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, SH3BP2, LCK, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Metyrosine | hsa04658 | Th1 and Th2 cell differentiation | 9.73E-03 | 6 | P20963, P09693, Q16539, P06239, Q9UL17, P13765 | CD247, CD3G, MAPK14, LCK, TBX21, HLA-DOB | More | | Metyrosine | hsa04659 | Th17 cell differentiation | 7.42E-03 | 7 | Q16539, P06239, P13765, P14778, Q9UL17, P09693, P20963 | MAPK14, LCK, HLA-DOB, IL1R1, TBX21, CD3G, CD247 | More | | Metyrosine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Metyrosine | hsa04919 | Thyroid hormone signaling pathway | 4.44E-02 | 3 | P60709, Q09472, P01106 | ACTB, EP300, MYC | More | | Metyrosine | hsa04924 | Renin secretion | 3.64E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Metyrosine | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | | Metyrosine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Metyrosine | hsa04962 | Vasopressin-regulated water reabsorption | 1.80E-02 | 2 | P62491, P46459 | RAB11A, NSF | More | | Metyrosine | hsa05016 | Huntington disease | 1.07E-02 | 3 | Q9GZM3, P52435, P55036 | POLR2J2, POLR2J, PSMD4 | More | | Metyrosine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 6.89E-03 | 2 | Q99437, P41240 | ATP6V0B, CSK | More | | Metyrosine | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Metyrosine | hsa05144 | Malaria | 1.91E-03 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Metyrosine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Metyrosine | hsa05163 | Human cytomegalovirus infection | 4.07E-02 | 9 | P01375, P63218, P50151, Q14643, P49841, P14778, P25025, Q16539, O00463 | TNF, GNG5, GNG10, ITPR1, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | | Metyrosine | hsa05164 | Influenza A | 8.62E-03 | 4 | Q09472, P48551, P29728, P60709 | EP300, IFNAR2, OAS2, ACTB | More | | Metyrosine | hsa05169 | Epstein-Barr virus infection | 2.92E-03 | 12 | P20023, P13765, P01106, Q13547, O00463, Q16539, P24522, P48551, O60603, P29728, P09693, P20963 | CR2, HLA-DOB, MYC, HDAC1, TRAF5, MAPK14, GADD45A, IFNAR2, TLR2, OAS2, CD3G, CD247 | More | | Metyrosine | hsa05171 | Coronavirus disease - COVID-19 | 1.93E-02 | 4 | P48551, P29728, P46777, P50914 | IFNAR2, OAS2, RPL5, RPL14 | More | | Metyrosine | hsa05211 | Renal cell carcinoma | 1.67E-02 | 2 | Q09472, Q99814 | EP300, EPAS1 | More | | Metyrosine | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | | Metyrosine | hsa05223 | Non-small cell lung cancer | 1.39E-02 | 3 | P10826, Q9HC35, O75293 | RARB, EML4, GADD45B | More | | Metyrosine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.66E-03 | 8 | P07766, P20963, P09693, P06239, O60603, Q16539, Q9HC35, P01730 | CD3E, CD247, CD3G, LCK, TLR2, MAPK14, EML4, CD4 | More | | Metyrosine | hsa05321 | Inflammatory bowel disease | 4.92E-02 | 4 | O60603, P01375, Q14765, Q9UL17 | TLR2, TNF, STAT4, TBX21 | More | | Metyrosine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Metyrosine | hsa05332 | Graft-versus-host disease | 2.02E-03 | 5 | P48023, P10747, P01375, P26715, Q13241 | FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Metyrosine | hsa05340 | Primary immunodeficiency | 1.28E-03 | 4 | P01730, P11912, P07766, P06239 | CD4, CD79A, CD3E, LCK | More | | |